Johnson & Johnson (JNJ) Tops Q4 EPS by 2c; offers 2025 guidance
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $239.08 +3.37%
Revenue Growth %: +5.1%
Financial Fact:
Sales to customers (Note 9): 17.82B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +5.1%
Financial Fact:
Sales to customers (Note 9): 17.82B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.04, $0.02 better than the analyst estimate of $2.02. Revenue for the quarter came in at $22.52 billion versus the consensus estimate of $22.46 billion.
GUIDANCE:
Johnson & Johnson sees FY2025 EPS of $10.50-$10.70, versus the consensus of $10.60.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- Worthington Industries (WOR) Misses Q4 EPS by 9c
- Axis Capital Limited Upgrades Infosys Ltd. (INFO:IN) (INFY) to Buy (1)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
